Uses
Topicort ® (desoximetasone ointment USP) 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Source: US FDA prescribing information
- Presentations
- 8
- Brands
- 1
- Manufacturers
- 1
- Available from stock
- 0
Desoximetasone is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It is available as ointment, cream and topical spray. MedsAcross supplies Desoximetasone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Corticosteroid, Corticosteroid Hormone Receptor Agonists
- ATC classification
- D07AC03 Desoximetasone · Corticosteroids for the skin, subgroup D07A, subgroup D07ACD07XC02 Desoximetasone · Corticosteroids for the skin, subgroup D07X, subgroup D07XC
- US FDA first approval
- 28 February 1977
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Topical
- Dosage forms
- Ointment, Cream, Topical spray, Gel
- Identifiers
- UNII 4E07GXB7AURxCUI 3255CAS 382-67-2DrugBank DB00547Q385370
Clinical information
From the regulator-approved product information. Each section names its source.
Dosing overview
Apply a thin film of Topicort ® (desoximetasone ointment USP) 0.05% to the affected skin areas twice daily. Rub in gently.
Source: US FDA prescribing information
Contraindications
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Source: US FDA prescribing information
Warnings and precautions
Keep out of reach of children.
Source: US FDA prescribing information
Side effects
The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. In controlled clinical studies the incidence of adverse reactions was low (0.2%) for Topicort ® (desoximetasone ointment USP) 0.05% and included mild burning sensation at the site of application.
Source: US FDA prescribing information
Storage
Store at controlled room temperature between 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
8 presentations of Desoximetasone, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Desoximetasone 0.25% creamTopicalGeneric name | — | US FDA | Available on request |
| Desoximetasone 0.25% ointmentTopicalGeneric name | — | US FDA | Available on request |
| Desoximetasone 0.05% ointmentTopicalGeneric name | — | US FDA | Available on request |
| Desoximetasone 2.5 mg/mL topical sprayTopicalGeneric name | — | US FDA | Available on request |
| Desoximetasone 0.05% creamTopicalGeneric name | — | US FDA | Available on request |
| Topicort 2.5 mg/mL topical sprayTopical | Sun Pharmaceutical IndustriesIndia | US FDA | Available on request |
| Topicort 0.05% ointmentTopical | Sun Pharmaceutical IndustriesIndia | US FDA | Available on request |
| Desoximetasone 0.05% gelTopicalGeneric name | — | US FDA | Available on request |
Brands by market
1 brand names across 1 markets.
United States
Manufacturers
Indian manufacturers are highlighted.
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 28 February 1977 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions
Conditions linked to Desoximetasone in public data. This is not a list of approved uses, see the clinical information.
Questions and answers
Is Desoximetasone available for export from India?
Yes, on request. MedsAcross lists 8 presentations of Desoximetasone and sources them for licensed hospitals, importers and physicians against valid import documents. Indian manufacturers include Sun Pharmaceutical Industries.
What brand names does Desoximetasone have?
The catalogue lists 1 brand names for Desoximetasone, including Topicort.
Is Desoximetasone approved by the US FDA?
Yes. The US FDA first approved Desoximetasone on 28 February 1977, according to Drugs@FDA.
Does Desoximetasone need cold chain shipping?
No listed presentation of Desoximetasone is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Desoximetasone in?
Desoximetasone is classified under ATC code D07AC03 (Desoximetasone).
References
- Topicort prescribing information (Sun Pharmaceutical Industries). U.S. National Library of Medicine, DailyMed. Retrieved 12 March 2026
Request Desoximetasone for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.